The present study was conducted to elucidate the role of oxidative stress and nuclear factor-kB (NF-kB) in the beneficial effects of angiotensin receptor blockade on obstructive nephropathy. Unilateral ureteral occlusion in rats elicited tubulo-interstitial fibrosis with concomitant macrophage infiltration and increased expression of monocyte chemoattractant protein-1. These changes were accompanied by an induction of renal cortical lipid peroxidation and activation of NF-kB. Both an AT1 antagonist, candesartan, and a NF-kB inhibitor, pyrrolidine dithiocarbamate, markedly attenuated these changes and to a similar extent. These results suggest that the beneficial effects of angiotensin blockade are mediated by the inhibition of oxidative stress and subsequent NF-kB activation in obstructive nephropathy.
Interstitial fibrosis is a major histological feature in many progressive renal diseases. The unilateral ureteral obstruction (UUO) animal model is a non-immune, nonproteinuric and non-lipidemic renal disorder that leads to progressive renal tubular atrophy and interstitial fibrosis (1) .
Angiotensin-converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) have been shown to have a beneficial effect in UUO (2) . ACEI treatment attenuated interstitial inflammation, suppressed gene expressions of fibrogenic molecules, and ameliorated interstitial fibrosis. While the renin-angiotensin system (RAS) has been implicated in the pathogenesis of interstitial fibrosis in UUO, the precise mechanisms remain unclear.
It is well known that nuclear factor-kB (NF-kB) plays a pivotal role in many inflammatory diseases (3) including renal disease (4, 5) . Reactive oxygen species (ROS) has been implicated as a contributing factor in a variety of tissue injuries (6) . Furthermore, ROS is a known stimulus of NF-kB activation.
In the present study, we examined the role of RAS and NF-kB in the pathogenesis of obstructive nephropathy. The first aim was to compare the effect of RAS blockade and that of NF-kB inhibition in the pathogenesis of interstitial fibrosis by UUO. The second aim was to investigate the role of ROS and NF-kB in the beneficial effect of RAS blockade. For this purpose, we treated UUO-operated rats with pyrrolidine dithiocarbamate (PDTC) (a putative NF-kB inhibitor with antioxidant property) or ARB (candesartan cilexitil).
The present experiments were conducted in accord with the Guideline Principles for the Care and Use of Laboratory Animals approved by The Japanese Pharmacological Society. Adult male Sprague-Dawley rats weighing 180 to 200 g were used in this experiment. Candesartan cilexitil (candesartan) was a gift from Takeda Chemical Industries, Ltd., Osaka. Candesartan was dissolved in water with CM-cellulose (5 mg /ml) to a final concentration of 3.3 mg /ml. PDTC (Sigma-Aldrich, Tokyo) was dissolved in distilled water to a final concentration of 200 mg /ml. All rats except sham-operated rats underwent unilateral ureteral obstruction. Under sodium pentobarbital (50 mg /kg, i.p.) anesthesia, a midline incision of lower abdomen was made and the left ureter was ligated with 4-0 silk at two points and cut between the ligatures. To examine the effect of ARB and NF-k B inhibition, rats were divided into 4 groups as follows: 1) unilateral ureteral ligated rats (N = 7), 2) unilateral ureteral ligated rats that received candesartan 10 mg /kg per day by gavage 1 h prior to and throughout UUO (N = 7), 3) unilateral ureteral ligated rats that received PDTC 200 mg /kg per day by gavage 1 h prior to and throughout UUO (N = 6), 4) sham-operated rats (N = 6). At 5 days after UUO, the left kidney was immediately excised, and the cortices were carefully dissected from the medulla, snap frozen in liquid nitrogen, and stored at -80°C until use for RNA extraction. A portion of renal cortical tissue was processed for measurement of malondialdehyde (MDA) and isolation of nuclear protein, respectively. The remaining renal tissues were fixed in 10% neutral-buffered formalin or methyl Carnoy's solution. Malondialdehyde in the supernatant of homogenized renal tissues was measured as thiobarbituric acid reactive substances (TBARS) by the colorimetric TBA reaction as described by Ohkawa et al. (7) . Nuclear protein extractions and electrophoretic mobility shift assay (EMSA) were performed as described previously (5) . The sequence of double-stranded oligonucleotide used for EMSA was as follows: consensus NF-kB, 5'-AGT TGA GGG GAC TTT CCC AGG C-3' (Promega, Madison, WI, USA). The sections of methyl Carnoy's solution-fixed renal tissue were stained with mouse monoclonal antibody to the rat mono-cyte /macrophage (ED-1, 1:500 dilution; Serotec, Oxford, UK) as described previously (5) . The sections of formalinfixed renal tissue sections were incubated with mouse monoclonal antibody to the rat a-smooth muscle actin (a -SMA) (Dako, Carpinteria, CA, USA). Histofine Simple Stain Rat MAX PO (MULTI) (Nichirei Corp., Tokyo) was used as secondary antibody according to manufacturer's instruction. RNA extracted by the guanidium thiocyanatephenol-chloroform method, as previously reported (8), was used for Northern blot analysis. A cDNA probe of rat monocyte chemoattractant protein-1 (MCP-1) was used as described previously (9) . Data are presented as the mean ± S.E.M. All data were analyzed by using ANOVA and individual comparisons were made by using Duncan's multiple range test. Statistical significance was defined as P<0.05.
Ureteral ligation caused a prominent injury consisting of tubular dilation, tubular atrophy and severe interstitial fibrosis. Both candesartan and PDTC treatment ameliorated interstitial fibrosis that was estimated by the percentage of a-SMA positive area. The a-SMA protein, which is a marker of tubulointerstitial myofibroblast responsible for a large component of the interstitial collagen deposition after UUO (10) , is expressed in the widened interstitial space during UUO (Fig. 1A) , whereas it was found only in blood vessels in sham-operated rats (not shown). The percentage of a -SMA positive area in UUO-operated rats was significantly increased compared to that of shamoperated rats (Fig. 1D ). Administration of either candesartan or PDTC markedly decreased a -SMA expression ( Fig. 1: B, C, D) . The inhibitory effect of candesartan was not different from that of PDTC.
Renal cortical NF-k B-DNA binding activity was significantly increased by UUO (Fig. 2) . Both candesartan and PDTC attenuated UUO-induced increase in NF-k B-DNA binding. With candesartan treatment, NF-k B-DNA binding activity was decreased to a level not different from that of PDTC-treated rats.
The renal cortical MDA concentration was significantly elevated in UUO-operated rats compared to that of shamoperated rats (0.430 ± 0.047 vs 0.190 ± 0.016 mMol/mg protein, P<0.05). This increase was completely blunted by either candesartan or PDTC treatment (0.215 ± 0.019, 0.247 ± 0.016, respectively, N.S. compared to that of sham-operated rats).
Monocyte /macrophage infiltration was increased by UUO (Fig. 3A) . It was predominantly detected in the widened interstitium around injured tubules. Monocyte /macrophage influx was attenuated by either candesartan or PDTC. In the candesartan-treated group, the number of monocyte /macrophage was not different from that observed in the PDTC-treated group. Gene expression of MCP-1, which is well known as a potent macrophage chemoattractant, was markedly enhanced in the UUO group (Fig. 3B) . Both candesartan and PDTC significantly attenuated this increase.
The present results suggest that in the obstructed nephropathy RAS contributes to the development of interstitial inflammation and fibrosis via NF-k B activation.
Activation of NF-kB transcription factor family plays a central role in various chronic inflammatory diseases (3). In our experiment, NF-k B-DNA binding was markedly activated by UUO. PDTC treatment in UUO successfully reduced NF-kB-DNA binding activity, and candesartan treatment could also block it. The magnitude of the inhibition was not different between these maneuvers. Previous reports suggested that ACEI treatment or angiotensin II type 1 receptor deficiency inhibited NF-kB activation that was enhanced by UUO (11, 12) . The authors speculated that the beneficial effect of RAS blockade might be due to decreased activation of NF-kB, although direct evidence is lacking in their reports. Our present finding confirmed that the beneficial effect of RAS blockade is mediated by the inhibition of NF-kB activation.
ROS is a known source of NF-kB activation (13) . As PDTC is one of the antioxidants, these results suggest that enhanced production of ROS following UUO activated NF-kB. The fact that candesartan also blocked MDA concentration and NF-kB strongly suggests that RAS stimulates ROS production that resulted in NF-kB activation. Indeed, a previous report showed that changes in RAS genes expression occur soon after ureteral obstruction (14) , suggesting the causative role of activated RAS. Although it is well known that angiotensin II increases production of ROS in both in vitro and in vivo studies (15, 16) , we demonstrated for the first time the role of RAS in the increased oxidative stress in the UUO animal model.
Monocyte /macrophage infiltration is one of the characteristic findings in UUO. We also showed that ED-1 positive cells were markedly increased by UUO. This increase was significantly suppressed by both candesartan and PDTC treatment. Infiltration of mononuclear cells into renal cortical interstitium of UUO-treated rats was associated with up-regulation of MCP-1, a potent macrophage chemoattractant. As NF-kB plays an important role in transcriptional control of MCP-1, NF-k B-dependent upregulation of MCP-1 expression is one of the likely mechanisms of monocyte /macrophage influx observed in the present study.
In summary, we demonstrated that angiotensin II induced ROS production and sequentially activated NF-kB in the UUO animal model. It is suggested that the beneficial effect of RAS blockade in the pathogenesis of obstructive nephropathy is mediated by the inhibition of oxidative stress and subsequent blockade of NF-kB activation.
